Market news

Mettler-Toledo International (MTD) is back in focus after fresh attention on its precision instruments business and diversified end markets, from pharmaceuticals to food manufacturing. Investors are reassessing the stock following this renewed spotlight. Recent trading has been lively for Mettler-Toledo International, with the share price climbing 20.08% over the past 90 days and 8.08% across the last month. The 1-year total shareholder return of 25.51% and 3-year total shareholder return of...

Detailed price information for Mettler-Toledo International (MTD-N) from The Globe and Mail including charting and trades.

Mettler-Toledo International (MTD) has an average rating of hold and mean price target of $1,477.31,

Weitz Investment Management, an investment management firm, released its second-quarter Q2 2026 investor letter for the “Multi Cap Equity Fund”. The letter can be downloaded here. The Multi Cap Equity Fund’s Institutional Class returned 7.90% in Q2, underperforming the Bloomberg U.S. 3000 Index’s 15.71% gain. Markets rose in the quarter on hopes of de-escalating Middle East […]

Detailed price information for Adv Micro Devices (AMD-Q) from The Globe and Mail including charting and trades.

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the research tools & consumables industry, including Mettler-Toledo (NYSE:MTD) and its peers.

Detailed price information for Mettler-Toledo International (MTD-N) from The Globe and Mail including charting and trades.

Mettler-Toledo International (MTD) has an average rating of hold and mean price target of $1,472.92,

Mettler-Toledo International (MTD) has an average rating of hold and mean price target of $1,472.75,

Mettler-Toledo has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Mettler-Toledo (MTD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Bank of America, Mettler-Toledo and VSE post strong gains as Zacks' Focus List, ECAP and Top 10 picks outperform.

Motley Fool Press Release.

This exercise-and-sell transaction captured a gain on options struck at $397.95.

Head of Process Analytics Gerry Keller liquidated stock worth $342,514 on August 3.

Vadala exercised stock options and liquidated the position same-day.

Salice exercised 415 stock options at $397.95 and immediately sold them at $1,444.62.

Detailed price information for Mettler-Toledo International (MTD-N) from The Globe and Mail including charting and trades.

In a new SEC filing on August 7, it was revealed that SALICE, Board Member at Mettler-Toledo Intl (NYSE:MTD), executed a significant exercise of company stock options. What Happened: A Form 4 filing with the U.S.

Detailed price information for Zscaler Inc (ZS-Q) from The Globe and Mail including charting and trades.

Detailed price information for Mettler-Toledo International (MTD-N) from The Globe and Mail including charting and trades.

Thomas P Salice, Director, on August 03, 2026, sold 415 shares in Mettler Toledo International (MTD)

Disclosed in a recent SEC filing on August 5, Keller, Head Process Analytics at Mettler-Toledo Intl (NYSE:MTD), made a noteworthy transaction involving the exercise of company stock options. What Happened: A notable

Mettler-Toledo International Inc. recently reported second-quarter 2026 results showing higher sales of US$1,027.31 million and net income of US$232.90 million, while also appointing MISTRAS Group CEO Natalia Shuman to its Board of Directors effective 3 August 2026. Together with Baron Capital’s decision to increase its long-held position after a recent pullback, these developments point to growing institutional engagement and fresh governance expertise focused on technology-enabled services...

Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index. Since inception, […]